NIH opens federal funding for 13 embryonic stem cell lines, will review 96 more. Dec. 2, 2009— -- The National Institutes of Health announced it will make 13 new embryonic stem cell lines will be ...

It asked the Union health ministry to propose a way forward for such patients/parents, in consultation with officials from ...

Lineage Cell Therapeutics (LCTX) announced the receipt of an induced pluripotent stem cell line containing hypoimmunity edits, from Factor Bioscience. Generation of the line marks a milestone in the ...

BTK inhibitors (BTKi) in mantle cell lymphoma (MCL) are examined by Tycel J. Phillips, MD, particularly as potential first-line therapy.

SEATTLE--(BUSINESS WIRE)--Pluristyx, a leading provider of Good Manufacturing Practices (GMP), cutting-edge, induced pluripotent stem cell (iPSC) technologies, today announced the immediate ...

The Supreme Court has ruled that stem cell therapy cannot be offered as a treatment for Autism Spectrum Disorder, calling its ...

A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. The Christmas Eve regulatory ...

Sugar Land has authorized an $1 million incentive for stem cell therapy company Hope Biosciences as city leaders look to ...

A new gene therapy for people who can have a stem cell transplant but do not have a suitable donor has been approved.